Menu
Recruiting NCT07161531

Test-retest Reliability of sEMG to Measure Fatigue in Adolescents

No phase Interventional Healthy Adolescents

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: Surface Electromyography.
Who it may be relevant to
Registry conditions: Healthy Adolescents. Basic parameters: 13 years — 19 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
Belgium
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Official title

Evaluating Test-Retest Reliability of Surface Electromyography (sEMG) in Measuring Fatigue in Adolescents Through Prolonged Activity

Overview

This cross-sectional study aims to determine the test-retest reliability of surface electromyography (sEMG) outcomes in detecting levels of fatigue among healthy adolescents engaged in physical activities. It seeks to evaluate the consistency of sEMG parameters across two test sessions and correlate these measurements with both performance metrics and subjective fatigue assessments. Participants will perform repetitive squatting until volitional exhaustion while their muscular activity is recorded. They will do so on two different test sessions with an interval of one week in between.

Interventions

  • Diagnostic test Surface Electromyography
    The primary lower limb muscles to be monitored include the gluteus medius, rectus femoris, vastus lateralis (quadriceps ), biceps femoris (hamstrings), tibialis anterior, and gastrocnemius medialis (calves). This setup fully utilizes a 16-channel sEMG system by monitoring each muscle group bilaterally to capture comprehensive data on muscle activity and fatigue.

Primary outcome measures

  • sEMG median power frequency (MPF) - test [Time frame: first test session at day 1]
  • sEMG median power frequency - retest [Time frame: second test session after 1 week]
  • sEMG RMS amplitude - test [Time frame: first test session at day 1]
  • sEMG RMS amplitude - retest [Time frame: second test session after 1 week]
Secondary outcome measures (2)
  • VAS score - test [Time frame: first test session at day 1]
  • VAS score - retest [Time frame: second session after 1 week]

Eligibility criteria

Inclusion criteria

  • engage in regular physical activity, such as sports or dance

Exclusion criteria

  • neuromuscular disorders
  • conditions that affect muscle function

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: Yes

Study design

Allocation
N/A
Model
Single group
Masking
Open label
Primary purpose
Basic science

Study locations

Belgium · 1 center
  • Universiteit Antwerpen, Department of Rehabilitation Sciences and Physiotherapy, Research — Wilrijk

Publications

  • Mokkink, L.B., de Vet, H., Diemeer, S. et al. Sample size recommendations for studies on reliability and measurement error: an online application based on simulation studies. Health Serv Outcomes Res Method 23, 241-265 (2023)
  • Patikas DA, Williams CA, Ratel S. Exercise-induced fatigue in young people: advances and future perspectives. Eur J Appl Physiol. 2018 May;118(5):899-910. doi: 10.1007/s00421-018-3823-1. Epub 2018 Feb 13. PMID 29441401
  • Lynn SK, Watkins CM, Wong MA, Balfany K, Feeney DF. Validity and Reliability of Surface Electromyography Measurements from a Wearable Athlete Performance System. J Sports Sci Med. 2018 May 14;17(2):205-215. eCollection 2018 Jun. PMID 29769821
  • Cifrek M, Medved V, Tonkovic S, Ostojic S. Surface EMG based muscle fatigue evaluation in biomechanics. Clin Biomech (Bristol). 2009 May;24(4):327-40. doi: 10.1016/j.clinbiomech.2009.01.010. Epub 2009 Mar 13. PMID 19285766

Identifiers

NCT: NCT07161531 · 6979

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗